Form D · Biotechnology
TRANSLUMINAL TECHNOLOGIES LLC
Syracuse, NY · CIK 0001433106
Offering snapshot reported Apr 21, 2020 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 23, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 21, 2020 | Initial | $1,500,000 | No comparison | 27 | SEC filing |
| May 20, 2015 | Amendment | $1,500,004 | $1,184,750vs Jan 27, 2014 | 32 | SEC filing |
| Jan 27, 2014 | Initial | $315,254 | No comparison | 5 | SEC filing |
| Apr 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $75K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-365431
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Pinnacle Investments, Inc. | 142910 |
Source: Form D, filed Apr 21, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Caputo | Director, Executive |
| Stephen M Green | Director, Executive |
| Denis L Harrington | Director |
| Mikio Miyawaki | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2930 E. Genesee St.
Syracuse, NY, 13224
Syracuse, NY, 13224